Your browser doesn't support javascript.
loading
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
Rudà, Roberta; Bruno, Francesco; Pellerino, Alessia; Pronello, Edoardo; Palmiero, Rosa; Bertero, Luca; Crasto, Stefania; Polo, Valentina; Vitaliani, Roberta; Trincia, Elena; Internò, Valeria; Porta, Camillo; Soffietti, Riccardo.
Afiliación
  • Rudà R; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy. rudarob@hotmail.com.
  • Bruno F; Department of Neurology, Castelfranco Veneto and Treviso Hospitals, Castelfranco Veneto, Italy. rudarob@hotmail.com.
  • Pellerino A; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.
  • Pronello E; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.
  • Palmiero R; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.
  • Bertero L; Neurology Unit, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Crasto S; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.
  • Polo V; Pathology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Vitaliani R; LARC and RIBA MRI Services, Turin, Italy.
  • Trincia E; Oncology Unit, Azienda Unità Locale Socio-Sanitaria (AULSS 2) Marca Trevigiana, Cà Foncello Hospital, Treviso, Italy.
  • Internò V; Division of Neurology, Cà Foncello Hospital, AULSS2 Marca Trevigiana, Treviso, Italy.
  • Porta C; Neuroradiology Unit, Cà Foncello Hospital, AULSS2 Marca Trevigiana, Treviso, Italy.
  • Soffietti R; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.
J Neurooncol ; 160(2): 389-402, 2022 Nov.
Article en En | MEDLINE | ID: mdl-36309895

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma Tipo de estudio: Observational_studies Límite: Humans / Middle aged Idioma: En Revista: J Neurooncol Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glioblastoma Tipo de estudio: Observational_studies Límite: Humans / Middle aged Idioma: En Revista: J Neurooncol Año: 2022 Tipo del documento: Article País de afiliación: Italia